右美托咪定对舌癌术后机械通气患者的镇静效果

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (3625 KB) RICH HTML
输出: BibTeX | EndNote (RIS)

摘要目的探讨右美托咪定对舌癌术后机械通气患者的镇静效果。方法选取2015-06至2017-06收治的80例舌癌术后行机械通气的患者,随机分为对照组(42例)和治疗组(38例)。对照组予以咪达唑仑镇静治疗,治疗组予以右美托咪定镇静治疗。比较两组患者机械通气时间、气管导管带管时间、ICU住院时间等指标;比较两组患者术后0、4、8 h的心率(HR)、平均动脉压(MAP)、血氧饱和度(SaO₂)和动脉氧分压PaO₂等血流动力学指标及血气分析指标;比较两组术后4、8、12 h的RASS评分,以及机械通气治疗期间的不良反应发生情况。结果手术后,治疗组机械通气时间、气管导管带管时间、ICU停留时间显著短于对照组(P<0.05或P<0.01)。术后4、8 h,两组HR、MAP、PaO₂水平均较同组0 h时有所改善,且治疗组4 h的HR、MAP显著优于对照组(P<0.05)。术后8、12 h,两组RASS评分均较术后4 h显著升高,治疗组术后8、12 h的RASS评分均显著高于对照组(P<0.05)。治疗组不良反应发生率为23.7%,对照组为26.2%。结论将右美托咪定应用于舌癌术后患者维持镇静效果显著。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	贵春梅
	李宏彬

关键词 ：右美托咪定, 咪达唑仑, 镇静, 机械通气, 舌癌, 谵妄

Abstract：Objective To investigate the effect of dexmedetomidine on mechanical ventilation patients after tongue cancer surgery.Methods Eighty mechanical ventilation patients after tongue cancer surgery were randomly divided into control group (n=42) and treatment group (n=38). The control group was treated with midazolam for sedation, while the treatment group was treated with dexmedetomidine. The duration of mechanical ventilation, indwelling time of the endotracheal tube and ICU stay in the hospital were compared between the two groups. The heart rate (HR), mean arterial pressure (MAP) and blood oxygen saturation(SaO₂), arterial oxygen pressure [p (O₂)] and hemodynamic parameters at 0, 4, 8 and 12 h after operation were compared. The RASS scores at 4, 8 and 12 h after operation and adverse reactions during mechanical ventilation were compared between the two groups.Results After operation, the treatment group had a significantly shorter time of mechanical ventilation, indwelling time of the endotracheal tube and the ICU stay than the control group (P<0.05 or P<0.01).At 4 and 8 h, HR, MAP and p (O₂) of the two groups were all improved than at 0 h, especially in the treatment group at 4 h (P<0.05). RASS scores in the two groups were significantly higher at 8, 12 h after operation than that at 4 h after operation, and those of the treatment group were significantly higher at 8, 12 h than in the control group (P<0.05). The incidence of adverse reactions was 23.7% in the treatment group, and 26.2% in the control group. The incidence of delirium in the treatment group was significantly lower than that in the control group (P<0.05). Conclusions Dexmedetomidine has significant effect on postoperative sedation for patients after tongue cancer surgery.

Key words： dexmedetomidine midazolam sedation mechanical ventilation tongue cancer delirium

收稿日期: 2017-12-20

ZTFLH:

R614.21

基金资助:湖南省卫生计生委科研计划课题横向项目(B2017189)

通讯作者: 李宏彬,E-mail:bbtang0129@sina.com

作者简介: 贵春梅,硕士,副主任医师。

引用本文:

贵春梅, 李宏彬. 右美托咪定对舌癌术后机械通气患者的镇静效果[J]. 武警医学, 2018, 29(3): 287-290. GUI Chunmei, LI Hongbin. Effect of dexmedetomidine on sedation in mechanical ventilation patients after tongue cancer surgery. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(3): 287-290.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2018/V29/I3/287

[1]	邱蔚六,张震康.口腔颌面外科学[M].6版.北京:人民卫生出版,2008:274.
[2]	钟少波,廖天安,郑长泰.舌癌200例临床疗效分析[J].中国热带医学,2007,7(5):759-760.
[3]	任振虎,吴汉江.舌癌手术治疗的进展[J].实用口腔医学杂志,2014,30(1):110-114.
[4]	伍俏媚,许庆,吴志,等.右美托咪定对舌癌患者围手术期炎症因子的影响[J/CD].中华口腔医学研究杂志:电子版,2016,10(1):51-54.
[5]	宋瑞霞,李俊艳,董晨明,等.右美托咪定在ICU机械通气集束化治疗中的临床应用研究[J].中华危重病急救医学,2015,6(10):836-840.
[6]	田鑫,莫立根,罗莹.临床N0期舌癌颈淋巴结转移相关因素及其外科处理[J].肿瘤防治研究, 2014,41(7):751-755.
[7]	毕展建,高飞,时玲燕,等.RASS评分对感染性休克患者改良早期目标导向治疗的探讨[J].中华医院感染学杂志,2016,26(19):4422-4424.
[8]	潘兴国,江泽琴,咸婧,等.舌癌综合治疗研究进展[J].西南军医,2007,9(6):105-106.
[9]	马朋林,李泰,刘京涛,等.镇静-镇痛策略与机械通气患者ICU不适经历关系的多中心调查研究[J].解放军医学杂志,2008,33(8):958-959.
[10]	徐安忆,洪广亮,赵光举,等.丙泊酚与咪达唑仑对急诊危重病机械通气患者镇静效果的比较研究[J].中华危重病急救医学,2013,25(6):356-359.
[11]	周兴.右美托咪定的药理作用及在临床中的应用[J].医学综述,2015,18(10):1552-1555.
[12]	Ji F, Li Z, Nguyen H, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery[J].Circulation, 2013, 127(15):1576-1584.
[13]	袁俊,何文宗,周咏,等.右美托咪定、咪达唑仑对急性左心衰竭机械通气患者的镇静作用[J].山东医药,2014,54(1):59-60.
[14]	王婧,奚望,殷亮,等.右美托咪定与丙泊酚对心脏瓣膜术后机械通气患者镇静效果及血流动力学的影响[J].第二军医大学学报,2017, 38(5):563-569.
[15]	Schoeler M, Loetscher P D, Rossaint R, et al. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury[J]. BMC Neurol, 2012(11):12-20.